This dynamic adaptability, often driven by intrinsic signaling pathways such as Notch, Wnt, MAPK, PI3K, and STAT3, allows subpopulations of cancer cells to evade therapy by transitioning into drug-tolerant or stem-like states (66). Here, STAT3 is linked to cancer.